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http://dx.doi.org/10.1016/j.kjms.201Abstract The use of succinylcholine and rocuronium are reportedly feasible during intrao-
perative neuromonitoring (IONM) of the recurrent laryngeal nerve (RLN) in thyroid surgery. This
study aimed to investigate and compare the recovery profiles of succinylcholine and rocuro-
nium on the laryngeal muscle during IONM of the RLN in a porcine model. Nine male Duroc-
Landrace piglets were anesthetized with thiamylal and underwent tracheal intubation without
neuromuscular blocking agents (NMBAs). Needle electrodes were inserted into the vocalis mus-
cles through the cricothyroid ligament. The RLN was exposed and stimulated. Electromyo-
graphic (EMG) signals were obtained before and after the intravenous administration of
a NMBA. The EMG amplitudes were measured before and after (at 1-minute intervals) the ad-
ministration of the study drug until complete recovery. The study NMBA regimen includedt of Otorhinolaryngology, Kaohsiung Medical University Hospital, Number 100, Tzyou 1st Road,
.tw (F.-Y. Chiang).
hsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
3.01.002
Recovery profile between different NMBAs 485succinylcholine (1 mg/kg), low-dose rocuronium (0.3 mg/kg), and standard dose rocuronium
(0.6 mg/kg). The maximal neuromuscular blockade and 80% recovery (i.e., duration) of the
control responses were recorded and analyzed. The 80% recovery of the control response for
succinylcholine (1 mg/kg) was 19.7  1.5 minutes; low-dose rocuronium (0.3 mg/kg),
16.3  2.5 minutes; and standard dose rocuronium (0.6 mg/kg), 29.3  5.7 minutes. Succinyl-
choline (1 mg/kg) and low-dose rocuronium (0.3 mg/kg) had significantly shorter durations
than standard dose rocuronium (0.6 mg/kg). The EMG signal recovery returned to baseline
within 30 minutes in the succinylcholine and low-dose rocuronium groups, but it did not return
to baseline until 1 hour after surgery in the rocuronium (0.6 mg/kg) group. In this study, suc-
cinylcholine (1 mg/kg) and low-dose rocuronium (0.3 mg/kg) had favorable recovery profiles on
the laryngeal muscle. It is recommended that low-dose rocuronium may replace succinylcho-
line for the induction of general anesthesia during IONM of the RLN in thyroid surgery.
Copyright ª 2013, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Intraoperative neuromonitoring (IONM) of the recurrent
laryngeal nerve (RLN) is commonly used in thyroid opera-
tions to prevent RLN injury [1e4]. However, trouble-
shooting IONM problems is persistently reported in the
literature. The misuse of neuromuscular blocking agents
(NMBAs) is a potential cause of unsuccessful IONM. To
achieve muscle relaxation for tracheal intubation and
operating conditions, administering a NMBA is usually
mandatory. However, a NMBA can reduce the electromyo-
graphic (EMG) amplitude and make monitoring less sensi-
tive to impending neural injury. When using a NMBA to
induce general anesthesia, it is best to allow all neuro-
muscular blockade drugs to wear off and a full return of
muscular activity as soon as possible after the intubation.
The use of depolarizing NMBAs (e.g., succinylcholine) or
nondepolarizing NMBAs (e.g., rocuronium) are reportedly
feasible during IONM of the RLN in thyroid surgery [5e7].
However, it is impossible to obtain the continuous recovery
profile of each NMBA in human subjects because of repea-
ted nerve stimulation at 1-minute intervals. Furthermore,
the dose of a NMBA and the timepoint of nerve stimulation
are critical for successful IONM. Therefore, it is necessary
to understand the recovery profile of different NMBAs at
different doses. This study used an established porcine
model with the aim of comparing the recovery profile of the
laryngeal muscle to succinylcholine and rocuronium (at
a low dose and the standard dose) and to find a relatively
optimal NMBA for IONM.Figure 1. The neuromonitoring setup of the recurrent lar-
yngeal nerve in a porcine model. The bilateral recurrent lar-
yngeal nerve (white arrows) is exposed and stimulated. A pair
of needle electrodes (black arrows) is inserted into the vocalis
muscles. Caud Z caudal; Ceph Z cephalad; TC Z thyroid
cartilage; Tr Z trachea.Materials and methods
Animals and anesthesia
Duroc-Landrace male piglets (n Z 9) weighing 18e20 kg
were obtained through the Kaohsiung Medical University,
Laboratory Animal Center (Kaohsiung, Taiwan). The piglets
were allocated into one of three groups, based on the
delivered NMBA regimen (each group had 3 piglets). The
animal use protocol was approved by the Institutional Ani-
mal Care and Use Committee of the Kaohsiung Medical
University (Kaohsiung, Taiwan) (protocol number 97146).The piglets were fasted for 8 hours, but were allowed water
before the experiment. The piglets were anesthetized with
4% sevoflurane in pure oxygen at a flow rate of 4 L/min and
were administered intravenous thiamylal (5 mg/kg). An
endotracheal tube (size #6) was then inserted without the
administration of a NMBA. General anesthesia was main-
tained with 1e3% sevoflurane and the piglets were con-
trolled ventilated. They were continuously monitored
through physiological monitors such as electrocardiography
(EKG), oximetry, end-tidal CO2, and airway pressure.
Equipment setting and experimental design
After surgical disinfection, a midline vertical cervical inci-
sion was created to expose the animal’s neck and larynx.
The RLNwas identified and dissected free from the overlying
soft tissue and fascia. Needle electrodes (Medtronic Xomed,
Jacksonville, FL) were inserted into the vocalis muscles
through the cricothyroid ligament. The channel leads from
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(Medtronic Xomed, Jacksonville, FL). A Prass monopolar
probe (Medtronic Xomed, Jacksonville, FL) was placed in
direct contact with the RLN for nerve stimulation (Fig. 1).
The stimuli for RLN stimulation were generated from the NIM
2.0 monitor. The stimulation level was set at 2.0 mA. The
NIM 2.0 monitor was set to run with a 50 millisecond time
window and an amplitude scale at 0.2 mV/division. Event
capture was activated with the threshold at 100 mV. Peak-to-
peak amplitudes of evoked EMG activity were directly read
on themonitor screen. Once stable baseline EMG amplitudes
were established, a bolus of a study drugdsuccinylcholine
(1 mg/kg), low-dose rocuronium (0.3 mg/kg), or standard
dose rocuronium (0.6 mg/kg)dwas delivered intravenously
within 5 seconds. Each piglet received only one regimen to
avoid a residual drug effect. The EMG amplitude was
immediately measured on completing the study drug
administration and repeated at 1-minute intervals there-
after until neuromuscular transmission attained at least 80%
recovery. The duration of each NMBA dose was defined as
the return to stability between 80% and 120% of the control
response (i.e., the baseline EMG amplitude). The non-
parametric data (e.g., EMG amplitude and duration) were
assessed by one-way ANOVA test. Data were presented as
the mean  the standard deviation (SD). A value of p < 0.05
was considered statistically significant.
Results
Baseline EMG amplitudes recorded directly from vocalis
muscle before the administration of succinylcholine (1 mg/
kg), low-dose rocuronium (0.3 mg/kg), and standard dose
rocuronium (0.6 mg/kg) were 2457  1994 mV,
2431  2571 mV, and 1277  513 mV, respectively. Succi-
nylcholine (1 mg/kg) and standard dose rocuronium
(0.6 mg/kg) achieved complete neuromuscular block (>95%
block). However, the maximal extent of the neuromuscular
block was only 87% with low-dose rocuronium (0.3 mg/kg).
The 80% recovery of the control responses for succinyl-
choline (1 mg/kg), low-dose rocuronium (0.3 mg/kg), andFigure 2. The recovery profile of the EMG signal of the
recurrent laryngeal nerve after a bolus of succinylcholine
(1 mg/kg), low-dose rocuronium (0.3 mg/kg), and standard
dose rocuronium (0.6 mg/kg). R0.3Z rocuronium (0.3 mg/kg);
R0.6 Z rocuronium (0.6 mg/kg); SCC1.0 Z succinylcholine
1.0 mg/kg.standard dose rocuronium (0.6 mg/kg) were 19.7  1.5
minutes, 16.3  2.5 minutes, and 29.3  5.7 minutes,
respectively. Succinylcholine (1 mg/kg) and low-dose
rocuronium (0.3 mg/kg) had a significantly shorter dura-
tion than standard dose rocuronium (0.6 mg/kg) (for both,
p < 0.05). Fig. 2 presents the recovery profile of the neu-
romuscular transmission of the laryngeal muscle after each
NMBA regimen. The EMG signal recovery returned to base-
line within 30 minutes in the succinylcholine and low-dose
rocuronium groups. However, it did not return to baseline
until an hour after the standard dose of rocuronium
(0.6 mg/kg).Discussion
A NMBA may diminish the evoked potential, delay a positive
signal, and interfere with data interpretation during IONM.
During neuromonitoring, a reduced dosage of rocuronium
may enable adequate muscle relaxation without sig-
nificantly affecting the measured evoked potentials [7]. It
lacks clinical comparisons of different kinds and different
dosages of NMBAs that directly and simultaneously monitor
neuromuscular transmission obtained from laryngeal mus-
cle via a neuromonitoring system. A porcine model of fea-
sibility and safety has been established to investigate the
effects of NMBAs on intraoperative neuromonitoring [8,9].
The primary results revealed that the standard dose of
succinylcholine (1.0 mg/kg) and a low dose of rocuronium
(0.3 mg/kg) have significantly shorter durations than the
standard dose of rocuronium (0.6 mg/kg) in the recovery
profile of the EMG signal of the RLN during neuro-
monitoring. According to our results, rocuronium has a sig-
nificant dose-response effect on the recovery profile.
Succinylcholine (1.0 mg/kg) and a single low dose of
rocuronium (0.3 mg/kg) both obtained complete EMG signal
recovery within 30 minutes. However, the EMG signal re-
covery did not return to baseline until 1 hour after the
standard dose of rocuronium (0.6 mg/kg). Therefore, low-
dose rocuronium shows a short duration and could replace
succinylcholine during neuromonitoring of the RLN in thy-
roid surgery.
The duration of neuromuscular blockade is of great
importance in IONM. The inhibition of neuromuscular
transmission diminishes EMG signals and motor-evoked po-
tentials and consequently interferes with interpreting neu-
romonitoring recordings [10,11]. To obtain adequate
relaxation for surgery and to obtain minimal variations in
EMG signals and motor-evoked potentials during neuro-
monitoring, it is important to administer nondepolarizing
NMBAs with caution (e.g., by using a single dose or con-
tinuous infusion) [7,12]. If NMBAs are avoided to ensure the
quality of the EMG signals or motor-evoked potentials,
a higher dose of inhalational or intravenous anesthetics may
be necessary at the expense of hemodynamic stability [12].
A shorter duration of neuromuscular blockade depicts
a more favorable recovery profile for neuromonitoring.
Among the three study regimens, low-dose rocuronium
(0.3 mg/kg) was the optimal choice during neuro-
monitoring. The benefits of low-dose rocuronium are the
following. The first benefit is the recovery profile. The
neuromuscular blocking duration of low-dose rocuronium
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within 30 minutes. This is approximately the same effect as
succinylcholine. Standard dose rocuronium (0.6 mg/kg)
showed a delayed and incomplete recovery in comparison
to low-dose rocuronium (0.3 mg/kg). The second benefit is
pharmacological safety. However, diverse adverse effects
ranging from minor (e.g., muscle pain, dysrhythmia) to le-
thal (e.g., malignant hyperthermia, hyperkalemia) limit its
clinical application [13,14]. Succinylcholine also has a short
duration; however, it is responsible for most incidents of
NMBA-related anaphylaxis [15]. Rocuronium is safer to use
than depolarizing NMBAs because it has fewer adverse ef-
fects than depolarizing agents. Furthermore, the hemody-
namic state remains stable with rocuronium, compared to
other nondepolarizing agents, because it does not induce
histamine release or vagal blockade [16]. Finally, rocuro-
nium at low dose provides acceptable tracheal intubation
conditions in most subjects [7,17]. In previous reports, the
further administration of a NMBA after a successful tracheal
intubation could be avoided in the entire thyroid surgery
[5e7]. The obvious disadvantage of low-dose rocuronium is
its incomplete neuromuscular blockade, which may lead to
prolonged onset time and difficulty in placing the endo-
tracheal tube.
There are several limitations in this study. First, the
sample size is small, which makes statistical analysis diffi-
cult. Second, the EMG amplitude has large variations so
that extreme individual readings may be misleading. How-
ever, the main analysis was based on the percent change
from the baseline and individual data depict good consis-
tency and reliability.
In conclusion, succinylcholine (1.0 mg/kg) and low-dose
rocuronium (0.3 mg/kg) showed a more favorable recovery
profile than standard dose rocuronium (0.6 mg/kg) during
neuromonitoring of the RLN. Titration of the rocuronium
dose to replace succinylcholine for neuromonitoring during
thyroid surgery is recommended. In this established porcine
model, the anatomic structure and electrophysiological
response of a piglet’s larynx are similar to the human lar-
ynx. However, translation of these data to humans should
be made cautiously.
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